High time to tackle childhood tuberculosis

Eurosurveillance

Volumn 16, Issue 12, 2011, Pages

  Haas, W ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID;

BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BCG VACCINATION; CHILD; CHILDHOOD DISEASE; DISEASE SURVEILLANCE; EDITORIAL; EPIDEMIC; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS CONTROL;

EID: 79953288915     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Koch R. Die Aetiologie der Tuberkulose. Berliner Klinische Wochenschrift. 1882;19(15):221-30.
2. European Centre for Disease Prevention and Control (ECDC)/ WHO Regional Office for Europe. Tuberculosis surveillance in Europe 2009. Stockholm: ECDC; 2011.
3. Schwoebel V, Rieder HL, Watson JM, Raviglione MC. Surveillance of tuberculosis in Europe. Euro Surveill. 1996;1(1):pii=200. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=200
4. Hollo V, Zucs P, Ködmön C, Sandgren A, Manissero D. Marking 15 years of efforts towards a comprehensive European TB surveillance system: the epidemiological situation of TB in the EU/EEA in 2009. Euro Surveill. 2011;16(12):pii=19822. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19822
5. Sandgren A, Hollo V, Quinten C, Manissero D. Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009. Euro Surveill. 2011;16(12):pii=19825. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19825
6. Bloch AB, Snider DE Jr. How much tuberculosis in children must we accept? Am J Public Health. 1986;76(1):14-5.
7. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995;346(8986):1339-45.
8. Guthmann JP, Antoine D, Fonteneau L, Che D, Lévy-Bruhl D. Assessing BCG vaccination coverage and incidence of pediatric tuberculosis following two major changes in BCG vaccination policy in France. Euro Surveill. 2011;16(12):pii=19824. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19824
9. World Health Organization (WHO). Immunization coverage with BCG at birth, 2009. Geneva: WHO; 27 Jul 2010. Available from: http://www.who.int/immunization_monitoring/diseases/BCG_coverage_map.jpg
10. Leung CC, Rieder HL, Lange C, Yew WW. Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J. 2011;37(3):690-711.
11. Abubakar I, Matthews T, Harmer D, Okereke E, Crawford K, Hall T, et al. Assessing the effect of foreign travel and protection by BCG vaccination on the spread of tuberculosis in a low incidence country, United Kingdom, October 2008 to December 2009. Euro Surveill. 2011;16(12):pii=19826. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19826
12. World Health Organization (WHO). WHO endorses new rapid tuberculosis test. Geneva: WHO; 8 Dec 2010. Available from: http://www.who.int/mediacentre/news/releases/2010/tb_test_20101208/en/index.html
13. European Centre for Disease Prevention and Control (ECDC). Call to action for childhood TB. Stockholm: ECDC. [Accessed 24 Mar 2011]. Available from: http://ecdc.europa.eu/en/healthtopics/spotlight/spotlight_tuberculosis_2011/Documents/Childhood_TB_2011_Call_to_action.pdf